• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期药物洗脱支架血栓形成的病理相关性:支架小梁覆盖率作为内皮化的标志物

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.

作者信息

Finn Aloke V, Joner Michael, Nakazawa Gaku, Kolodgie Frank, Newell John, John Mike C, Gold Herman K, Virmani Renu

机构信息

Cardiac Unit, Department of Internal Medicine, Massachusetts General Hospital, Boston, USA.

出版信息

Circulation. 2007 May 8;115(18):2435-41. doi: 10.1161/CIRCULATIONAHA.107.693739. Epub 2007 Apr 16.

DOI:10.1161/CIRCULATIONAHA.107.693739
PMID:17438147
Abstract

BACKGROUND

Late stent thrombosis (LST) after Cypher and Taxus drug-eluting stent placement has emerged as a major concern. Although the clinical predictors of LST have been reported, specific morphological and histological correlates of LST remain unknown.

METHODS AND RESULTS

From a registry totaling 81 human autopsies of drug-eluting stents, 46 (62 lesions) had a drug-eluting stent implanted >30 days. We identified 28 lesions with thrombus and compared those with 34 of similar duration without thrombosis using computer-guided morphometric and histological analyses. LST was defined as an acute thrombus within a coronary artery stent in place >30 days. Multiple logistic generalized estimating equations modeling demonstrated that endothelialization was the best predictor of thrombosis. The morphometric parameter that best correlated with endothelialization was the ratio of uncovered to total stent struts per section. A univariable logistic generalized estimating equations model of occurrence of thrombus in a stent section versus ratio of uncovered to total stent struts per section demonstrated a marked increase in risk for LST as the number of uncovered struts increased. The odds ratio for thrombus in a stent with a ratio of uncovered to total stent struts per section >30% is 9.0 (95% CI, 3.5 to 22).

CONCLUSIONS

The most powerful histological predictor of stent thrombosis was endothelial coverage. The best morphometric predictor of LST was the ratio of uncovered to total stent struts. Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of LST.

摘要

背景

西罗莫司和紫杉醇药物洗脱支架置入术后的晚期支架内血栓形成(LST)已成为一个主要问题。尽管已有LST的临床预测因素报道,但LST具体的形态学和组织学关联仍不清楚。

方法与结果

在一项总计81例药物洗脱支架人体尸检的登记研究中,46例(62个病变)植入药物洗脱支架超过30天。我们识别出28个有血栓的病变,并使用计算机辅助形态测量和组织学分析将其与34个持续时间相似但无血栓形成的病变进行比较。LST定义为冠状动脉支架内植入30天以上的急性血栓。多因素逻辑广义估计方程模型显示,内皮化是血栓形成的最佳预测因素。与内皮化最相关的形态学参数是每切片未覆盖支架支柱与总支架支柱的比例。支架切片内血栓形成与每切片未覆盖支架支柱与总支架支柱比例的单因素逻辑广义估计方程模型显示,随着未覆盖支柱数量增加,LST风险显著增加。每切片未覆盖支架支柱与总支架支柱比例>30%的支架内血栓形成的比值比为9.0(95%CI,3.5至22)。

结论

支架内血栓形成最有力的组织学预测因素是内皮覆盖。LST最佳的形态学预测因素是未覆盖支架支柱与总支架支柱的比例。愈合异质性是LST证据的药物洗脱支架中的常见发现,表明支架段愈合不完全在LST病理生理学中的重要性。

相似文献

1
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.晚期药物洗脱支架血栓形成的病理相关性:支架小梁覆盖率作为内皮化的标志物
Circulation. 2007 May 8;115(18):2435-41. doi: 10.1161/CIRCULATIONAHA.107.693739. Epub 2007 Apr 16.
2
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.药物洗脱支架在人体中的病理学:愈合延迟和晚期血栓形成风险。
J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5.
3
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.经皮冠状动脉介入治疗中使用紫杉醇洗脱支架相关的支架内血栓形成风险是多少?一项荟萃分析。
J Am Coll Cardiol. 2005 Mar 15;45(6):941-6. doi: 10.1016/j.jacc.2004.11.064.
4
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.比较不同药物洗脱支架在真实世界冠心病患者中的晚期支架血栓形成发生率:三年随访结果。
Chin Med J (Engl). 2010 Apr 5;123(7):778-81.
5
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.依维莫司洗脱支架与紫杉醇洗脱支架的随机对照比较:来自Xience V依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估(SPIRIT)III试验的两年临床随访
Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.
6
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.药物洗脱支架的长期安全性和有效性:REAL(艾米利亚-罗马涅血管成形术注册研究)多中心注册研究的两年结果。
Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11.
7
Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.西罗莫司洗脱支架的新生内膜覆盖不完全:血管内镜检查结果
J Am Coll Cardiol. 2006 May 16;47(10):2108-11. doi: 10.1016/j.jacc.2005.11.092. Epub 2006 Apr 4.
8
Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.对36例冠状动脉药物洗脱支架置入术后晚期血栓形成病例的分析。
Am J Cardiol. 2007 Apr 15;99(8):1039-43. doi: 10.1016/j.amjcard.2006.12.025. Epub 2007 Feb 23.
9
Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.雷帕霉素洗脱支架植入三个月后新生内膜覆盖情况的光学相干断层扫描评估。
Am J Cardiol. 2007 Apr 15;99(8):1033-8. doi: 10.1016/j.amjcard.2006.11.068. Epub 2007 Feb 23.
10
Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.一项关于基于可生物降解聚合物的雷帕霉素洗脱印度药物洗脱冠状动脉支架的临床前和早期临床经验:BIO-RAPID研究。
Indian Heart J. 2008 May-Jun;60(3):228-32.

引用本文的文献

1
Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent.无药物涂层聚合物的生物雷帕霉素洗脱支架与超薄支可降解聚合物西罗莫司洗脱支架的五年随访结果
EuroIntervention. 2025 Jun 2;21(11):e617-e628. doi: 10.4244/EIJ-D-24-00586.
2
Smart materials strategy for vascular challenges targeting in-stent restenosis: a critical review.针对支架内再狭窄的血管挑战的智能材料策略:批判性综述。
Regen Biomater. 2025 Mar 24;12:rbaf020. doi: 10.1093/rb/rbaf020. eCollection 2025.
3
Artificial Intelligence-Based Algorithm for Stent Coverage Assessments.
基于人工智能的支架覆盖评估算法
J Pers Med. 2025 Apr 11;15(4):151. doi: 10.3390/jpm15040151.
4
Comparison of very early-phase vascular response to the CD34 antibody‑covered sirolimus‑eluting stent versus durable polymer-coated everolimus-eluting stent.CD34抗体包被的西罗莫司洗脱支架与耐用聚合物涂层依维莫司洗脱支架的极早期血管反应比较。
Cardiovasc Interv Ther. 2025 Apr 18. doi: 10.1007/s12928-025-01114-9.
5
Deep learning model DeepNeo predicts neointimal tissue characterization using optical coherence tomography.深度学习模型DeepNeo利用光学相干断层扫描预测新生内膜组织特征。
Commun Med (Lond). 2025 Apr 17;5(1):124. doi: 10.1038/s43856-025-00835-5.
6
Innovations in Vascular Repair from Mechanical Intervention to Regenerative Therapies.血管修复的创新:从机械干预到再生疗法
Tissue Eng Regen Med. 2025 Feb 8. doi: 10.1007/s13770-024-00700-x.
7
Vascular Healing After Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Stents in Chronic Total Occlusions.慢性完全闭塞病变中可降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架后的血管愈合情况
Catheter Cardiovasc Interv. 2025 Apr;105(5):1124-1133. doi: 10.1002/ccd.31423. Epub 2025 Jan 29.
8
Visualization of Vulnerable Coronary Plaque and Prevention of Plaque Rupture.易损冠状动脉斑块的可视化与斑块破裂的预防
Juntendo Iji Zasshi. 2024 Jun 15;70(4):260-268. doi: 10.14789/jmj.JMJ24-0011-R. eCollection 2024.
9
Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT).非ST段抬高型急性冠状动脉综合征患者植入新一代药物洗脱支架后的早期血管愈合:一项随机光学相干断层扫描成像研究(EXPECT)
Int J Cardiovasc Imaging. 2024 Oct 12. doi: 10.1007/s10554-024-03258-w.
10
Widespread Use of Imaging-Guided PCI in Asia: Time for Extended Application.亚洲成像引导下经皮冠状动脉介入治疗的广泛应用:是时候扩大应用范围了。
JACC Asia. 2024 Aug 20;4(9):639-656. doi: 10.1016/j.jacasi.2024.07.003. eCollection 2024 Sep.